MedTech Resources

Device type · OYC

Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about OYC: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

OYC

Clinical Chemistry

Device class

Class III

FDA decisions since 2015

3

510(k), De Novo and PMA

Adverse event reports

9,588

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor
Product code
OYC
Device class
Class III
Review panel
Clinical Chemistry

Latest FDA decisions

All decisions for OYC

Reports received

9,588

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

9,479

99% of reports

Injury reports

108

1.1% of reports

Death reports

1

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 231,5432220
Jan 242,1902370
Feb 241,818710
Mar 241,5002450
Apr 241,113920
May 241,6563620
Jun 247072710
Jul 241,5872240
Aug 241,3821430
Sep 241,4042320
Oct 241,2141500
Nov 241,160600
Dec 241,630800
Jan 251,164900
Feb 25675310
Mar 251,032200
Apr 251,161700
May 25909900
Jun 251,008620
Jul 251,079610
Aug 25985720
Sep 251,505410
Oct 251,055300
Nov 25658500
Dec 251,061500
Jan 268782500
Feb 269571100
Mar 268421600
Apr 26745410
May 26621500
Jun 26741500
Jul 26857200
Aug 26629200
Sep 26790200
Oct 267002600
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Obstruction of Flow2,193
  • Break1,819
  • Material Integrity Problem1,319
  • Power Problem872
  • Key or Button Unresponsive/not Working791
  • Mechanical Problem757
  • Fracture700
  • Battery Problem675
  • No Display/Image576
  • Display or Visual Feedback Problem316

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions8,874
  • Hyperglycemia633
  • Hypoglycemia86
  • Elevated Ketones/ Diabetic Ketoacidosis50
  • Malaise36
  • Vomiting26
  • Fatigue15
  • Headache13
  • Discomfort12
  • Loss of consciousness8

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Medtronic MiniMed, Inc.

    Z-1743-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026

    Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...

    Cause as FDA categorized it: Device Design

  • Medtronic MiniMed, Inc.

    Z-1745-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026

    Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...

    Cause as FDA categorized it: Device Design

  • Medtronic MiniMed, Inc.

    Z-1746-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026

    Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...

    Cause as FDA categorized it: Device Design

  • Medtronic MiniMed, Inc.

    Z-1747-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026

    Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...

    Cause as FDA categorized it: Device Design

  • Medtronic MiniMed, Inc.

    Z-1749-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026

    Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...

    Cause as FDA categorized it: Device Design

  • Medtronic MiniMed, Inc.

    Z-1750-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026

    Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...

    Cause as FDA categorized it: Device Design

  • Medtronic MiniMed, Inc.

    Z-1256-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025

    Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...

    Cause as FDA categorized it: Device Design

  • Medtronic MiniMed, Inc.

    Z-1257-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025

    Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...

    Cause as FDA categorized it: Device Design

Showing the 8 newest of 34 recall records in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.